The drug Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that binds to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells. It activates endogenous T cells by connecting CD3 in the T-cell receptor (TCR) complex with CD19 on benign and malignant B cells. Blinatumomab Medicine is used in treating patients who have relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children. Blinatumomab is produced in Chinese hamster ovary cells. The single-dose vials come in 35 mcg to administer intravenously. This drug is supplied in a single-dose vial as a sterile, preservative-free, white to off-white lyophilized powder. The most Blincyto side effects are infections, fever, headache, low red blood cell count (anemia),low platelet count (thrombocytopenia) and reactions related to infusion of the medicine.
Blincyto is readily available with several generic medicine suppliers in India. To know more about this drug, contact us on 18008891064.